IP vs SUPN · P/E 43, $26.62B cap vs rev $661.8M
International Paper (IP) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the IP and SUPN stock pages for the full models.
Not investment advice.